Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Postgastrectomy Syndromes 1Metabolic Syndrome 1Metabolic Diseases 1Insulin Resistance 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gastric Bypass × Clear all
NCT01714622 2019-03-29

Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance

Yonsei University

Withdrawn
Gastrointestinal

Insulin Resistance, Metabolic Diseases, Stomach Neoplasms, Metabolic Syndrome

NCT00622804 2009-08-03

Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy

The Catholic University of Korea

Phase 3 Withdrawn
90 enrolled
Gastrointestinal

Postgastrectomy Syndromes, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡